Revision history of "GSHresistant and extremely cytoselective rutheniumIIpcymeneimidazo45f110phenanthrolin2ylphenol complexes as prospective anticancer brokers"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 20:34, 27 April 2024‎ Turretscene9 (Talk | contribs)‎ . . (3,668 bytes) (+3,668)‎ . . (Created page with "41, 95%CI One.47-3.97, p  a smaller amount then  0.005) as well as TLF (Hazard proportion 1.29, 95%CI 1.01-1.Sixty-five, p = 0.040). Your ROC necessities e...")
Retrieved from "http://eechcentral.simhq.com/index.php?title=GSHresistant_and_extremely_cytoselective_rutheniumIIpcymeneimidazo45f110phenanthrolin2ylphenol_complexes_as_prospective_anticancer_brokers"